Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27207 | 193 | 20.2 | 57% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1013 | 9860 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//TETRACYCLINES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CEFQUINOME | Author keyword | 13 | 49% | 10% | 19 |
| 2 | PORPHYROMONAS LEVII | Author keyword | 6 | 80% | 2% | 4 |
| 3 | BOVINE NECROTIC VULVOVAGINITIS | Author keyword | 3 | 100% | 2% | 3 |
| 4 | CEFTIOFUR | Author keyword | 3 | 18% | 8% | 16 |
| 5 | CLIN BACTERIOL MYCOL | Address | 2 | 26% | 4% | 8 |
| 6 | ANTIBIOTIC MUTAGENESIS | Author keyword | 2 | 67% | 1% | 2 |
| 7 | INTEGRAL DENT | Address | 2 | 67% | 1% | 2 |
| 8 | CEFTIOFUR HYDROCHLORIDE | Author keyword | 2 | 50% | 2% | 3 |
| 9 | DESFUROYLCEFTIOFUR | Author keyword | 1 | 100% | 1% | 2 |
| 10 | EXTREME TREATMENT CONDITION | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CEFQUINOME | 13 | 49% | 10% | 19 | Search CEFQUINOME | Search CEFQUINOME |
| 2 | PORPHYROMONAS LEVII | 6 | 80% | 2% | 4 | Search PORPHYROMONAS+LEVII | Search PORPHYROMONAS+LEVII |
| 3 | BOVINE NECROTIC VULVOVAGINITIS | 3 | 100% | 2% | 3 | Search BOVINE+NECROTIC+VULVOVAGINITIS | Search BOVINE+NECROTIC+VULVOVAGINITIS |
| 4 | CEFTIOFUR | 3 | 18% | 8% | 16 | Search CEFTIOFUR | Search CEFTIOFUR |
| 5 | ANTIBIOTIC MUTAGENESIS | 2 | 67% | 1% | 2 | Search ANTIBIOTIC+MUTAGENESIS | Search ANTIBIOTIC+MUTAGENESIS |
| 6 | CEFTIOFUR HYDROCHLORIDE | 2 | 50% | 2% | 3 | Search CEFTIOFUR+HYDROCHLORIDE | Search CEFTIOFUR+HYDROCHLORIDE |
| 7 | DESFUROYLCEFTIOFUR | 1 | 100% | 1% | 2 | Search DESFUROYLCEFTIOFUR | Search DESFUROYLCEFTIOFUR |
| 8 | EXTREME TREATMENT CONDITION | 1 | 100% | 1% | 2 | Search EXTREME+TREATMENT+CONDITION | Search EXTREME+TREATMENT+CONDITION |
| 9 | NECROTIC VULVOVAGINITIS | 1 | 100% | 1% | 2 | Search NECROTIC+VULVOVAGINITIS | Search NECROTIC+VULVOVAGINITIS |
| 10 | CELL CYCLE EFFECT | 1 | 33% | 1% | 2 | Search CELL+CYCLE+EFFECT | Search CELL+CYCLE+EFFECT |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DESFUROYLCEFTIOFUR | 24 | 68% | 11% | 21 |
| 2 | MULTIPLE INTRAMUSCULAR ADMINISTRATIONS | 12 | 86% | 3% | 6 |
| 3 | NECROTIC VULVO VAGINITIS | 6 | 80% | 2% | 4 |
| 4 | PORPHYROMONAS LEVII | 1 | 33% | 1% | 2 |
| 5 | AFRICAN GRAY PARROTS | 1 | 50% | 1% | 1 |
| 6 | INTRAMUSCULAR TREATMENT | 1 | 50% | 1% | 1 |
| 7 | LEVII | 1 | 50% | 1% | 1 |
| 8 | SUIS COINFECTION | 1 | 50% | 1% | 1 |
| 9 | CEFTIOFUR SODIUM | 0 | 15% | 2% | 3 |
| 10 | CEPHALOSPORIN CEFQUINOME | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| A comprehensive review of ceftiofur sodium and hydrochloride formulations for treatment of acute bovine foot rot | 2003 | 3 | 4 | 50% |
| Ceftiofur sodium: Absorption, distribution, metabolism, and excretion in target animals and its determination by high-performance liquid chromatography | 1996 | 1 | 6 | 83% |
| Molecular modeling studies of ceftiofur - A tool for hapten design and monoclonal antibody production | 1996 | 2 | 25 | 48% |
| MANAGEMENT OF 21 EMERGING LIVESTOCK DISEASES BY THE ISRAEL VETERINARY SERVICES | 2008 | 0 | 32 | 9% |
| Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: A review and re-analysis of published data .1. Clinical pharmacology | 1997 | 3 | 30 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN BACTERIOL MYCOL | 2 | 26% | 4.1% | 8 |
| 2 | INTEGRAL DENT | 2 | 67% | 1.0% | 2 |
| 3 | ANIM HLTH PROD DEV | 1 | 33% | 1.0% | 2 |
| 4 | BRAIN DEV MODULAT REPAIR | 1 | 50% | 0.5% | 1 |
| 5 | ISRAEL VET SERV | 1 | 50% | 0.5% | 1 |
| 6 | PHARMACOL PHYSIOL PHYSIOL CHEM | 1 | 50% | 0.5% | 1 |
| 7 | SURG ANAESTHET DOMEST ANIM | 1 | 50% | 0.5% | 1 |
| 8 | ANIM HLTH WELF VET PHARMACOL TOXICOL | 0 | 33% | 0.5% | 1 |
| 9 | DRUG IDUE STUDIES | 0 | 33% | 0.5% | 1 |
| 10 | EQUINE MEDICAT SURVEILLANCE | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000238778 | VET BASIC MED SCI//CYCLOSPORINE METABOLISM//DOSE REGIME |
| 2 | 0.0000207368 | MARBOFLOXACIN//ENROFLOXACIN//DANOFLOXACIN |
| 3 | 0.0000196620 | RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION |
| 4 | 0.0000165175 | PENICILLINS//CEPHALOSPORINS//AMOXICILLIN |
| 5 | 0.0000161576 | FELL PONY//TRANSFER OF IMMUNITY//FAILURE OF PASSIVE TRANSFER |
| 6 | 0.0000148814 | PHARMAKOL PHARM TOXIKOL//EXTRA LABEL USE//SUPPLY TO ANIMAL OWNERS |
| 7 | 0.0000130900 | CATEDRA BIOFIS//PREMI R TEST//ANTIBIOTIC RESIDUES |
| 8 | 0.0000127990 | LONG ACTING OXYTETRACYCLINE//LOCAL TOLERANCE//CAS 24390 14 5 |
| 9 | 0.0000125619 | CHEMOTHERAPY-TOKYO//BACTERIOLOGICAL RESPONSE//SULPHIMIDAZOLE |
| 10 | 0.0000095712 | CEFEPIME//CEFPIROME//FK037 |